secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kailera Therapeutics, Inc. (KLRA)
CIK:        0002096997
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001193125-26-164040
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kailera Therapeutics closes IPO raising $718.8M; issues 44.9M shares at $16.00
------------------------------------------------------------------------------

- Closed IPO of 44,921,875 shares at $16.00 per share, including full exercise of underwriters' option for 5,859,375 additional shares.
- Gross proceeds of $718.8 million before underwriting discounts and offering expenses.
- Amended certificate of incorporation: authorized 800M shares of common stock and 10M shares of undesignated preferred stock.
- Adopted classified board with staggered three-year terms; directors removable only for cause with two-thirds vote.
- Amended bylaws to require advance notice for stockholder proposals and director nominations, and limit action by written consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2096997/000119312526164040/0001193125-26-164040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2096997/000119312526164040/d137434d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-164040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer